UBS Group AG - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$4,15924,463
+3930.1%
0.00%
Q3 2022$0
-100.0%
607
-81.3%
0.00%
Q2 2022$3,000
+50.0%
3,248
+176.9%
0.00%
Q3 2021$2,000
-33.3%
1,173
-15.9%
0.00%
Q4 2020$3,000
+200.0%
1,394
+176.6%
0.00%
Q2 2020$1,000
-87.5%
504
-91.0%
0.00%
Q1 2020$8,000
+100.0%
5,614
+126.3%
0.00%
Q3 2019$4,0000.0%2,481
+98.6%
0.00%
Q1 2019$4,000
-78.9%
1,249
-89.4%
0.00%
Q4 2018$19,000
+280.0%
11,793
+319.7%
0.00%
Q2 2018$5,0002,810
+2738.4%
0.00%
Q4 2017$0
-100.0%
99
-95.4%
0.00%
Q3 2017$13,0000.0%2,172
-20.5%
0.00%
Q2 2017$13,000
-74.0%
2,733
-39.8%
0.00%
Q1 2017$50,000
-67.1%
4,537
-79.1%
0.00%
Q4 2016$152,000
-19.6%
21,702
-2.4%
0.00%
Q3 2016$189,000
-45.2%
22,228
-13.1%
0.00%
Q2 2016$345,000
+1816.7%
25,573
+1358.0%
0.00%
Q1 2016$18,000
+80.0%
1,754
+143.6%
0.00%
Q4 2015$10,000
-52.4%
720
-17.1%
0.00%
Q3 2015$21,0008680.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Omnia Family Wealth, LLC 467,085$761,0000.52%
Hikari Power Ltd 89,815$146,0000.02%
NEA Management Company, LLC 452,167$737,0000.01%
Truvestments Capital LLC 1,621$3,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$49,0000.00%
MILLENNIUM MANAGEMENT LLC 15,276$25,0000.00%
MORGAN STANLEY 5,539$9,0000.00%
Renaissance Technologies 65,350$107,0000.00%
Citadel Advisors 37,770$62,0000.00%
HighTower Advisors, LLC 20,000$33,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders